visualvisitorlogo
  • Our Platform downarrow
    Powerful Sales
    Intelligence     dashboard
    Platform Overview
    Buyer Intent Data
    B2B Prospect Data     Website Visitor ID Email Tracking
  • Why?downarrow
    Your Challenges Our Data See For Yourself
  • Pricing
  • Resourcesdownarrow
    Resellers
    Add Onsdrop
    Call Tracking     Keyword Level Tracking Reputation Management
    Integrations About Us
    Contactdrop
    Atlanta Jacksonville
    Blog Careers Support
    • Login Free Trial Schedule A Demo
    × Our Platform downarrow
    Why? downarrow
    Pricing Resources downarrow
    visualvisitorlogo ☰

    Myovant Sciences

    Get Full Access

    Description

    • Myovant Sciences is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for women's health diseases and other endocrine-related disorders. Myovant's lead product candidate is relugolix, an oral, once-daily, small molecule that acts as a GnRH receptor antagonist. Myovant is in the process of initiating five international Phase 3 clinical trials for relugolix, two in women with heavy menstrual bleeding associated with uterine fibroids, two in women with endometriosis-associated pain, and one in men with advanced prostate cancer. Myovant is simultaneously developing MVT-602, an analog of kisspeptin, for the treatment of female infertility as part of assisted reproduction. Over time, the company intends to expand its development pipeline to include other potential treatments for women's health and endocrine-related disorders. For more information, please visit the company's website at myovant.com.
    • location

      Headquarters:2000 Sierra Point Parkway , Brisbane, California, United States

      More
    • Myovant Sciences phone

      Phone Number: +1 650-238-0250

    • Myovant Sciences website

      Website: https://www.myovant.com

    • Myovant Sciences employees

      Employees:282

    • Myovant Sciences revenue

      Revenue:$250 - 500M

    • Myovant Sciences legal name

      Legal Name:Myovant Sciences

    • Myovant Sciences's Social Media

      Myovant Sciences linkedin Myovant Sciences twitter
    • done Is this data correct?

    • |  NAICS Code: 424210  |

      Show More
    Person level website identification

    CEO for Myovant Sciences

    David Marek

    Chief Executive Officer

    Person level website visitor identification

    Sell more in less time!

    Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

    View Employees

    Juan Ferreira

    Chief Medical Officer

    Lina Alsibai

    Ea To Chief Marketing Officer, Senior Vice President Of Clinical Development And Senior Vice President Of Regulatory Affairs And Quality Assurance

    Frank Karbe

    President And Chief Financial Officer

    Lauren Merendino

    Chief Commercial Officer

    Mark Guinan

    Board Member

    Frequently Asked Questions regarding Myovant Sciences

    • Where are Myovant Sciences's Headquarters?

      Myovant Sciences's Headquarters are in 2000 Sierra Point Parkway ,Brisbane,California,United States

    • What is Myovant Sciences's phone number?

      Myovant Sciences's phone number is +1 650-238-0250

    • What is Myovant Sciences's official website?

      Myovant Sciences's official website is https://www.myovant.com

    • What is Myovant Sciences's Revenue?

      Myovant Sciences's revenue is $250 - 500M

    • What is Myovant Sciences's NAICS code?

      Myovant Sciences's NAICS code is 424210

    • How many employees are working in Myovant Sciences

      Myovant Sciences has 282 employees

    • What is Myovant Sciences's Industry?

      Myovant Sciences is in the industry of Biotechnology

    • Who is Myovant Sciences's CEO?

      Myovant Sciences's CEO is David Marek

    Company Directory